Gerresheimer Extends Medical Devices Operations in US

Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, is extending its production capacity for medical plastic systems at its plant in Peachtree City, GA. The production area will be increased by an additional 60,000 sq ft. Production of new medical devices will start right after completion of the infrastructural enlargements. Gerresheimer is investing millions of dollars in the project in Peachtree City, which will create around 120 additional jobs in the medium-term future.

“We’re experiencing worldwide growth in demand for user-friendly, safe, and easy-to-use medical devices, such as inhalers and insulin pens. As a result of this growth, and new customer projects, our excellent plant in Peachtree City will be significantly increasing its production capacity. There are a great many opportunities for us in this business segment in the US, and our Peachtree City facility will play a crucial role in helping us to exploit them. We greatly appreciate the generous support of the state and local authorities in Georgia in this challenging project,” commented Andreas Schütte, member of the management board of Gerresheimer AG with responsibility for the Plastics & Devices Division.

The additional production area will significantly increase Gerresheimer’s Peachtree City plant’s production capacity. Two thirds of the additional production area will be ISO class 8 cleanroom.

Gerresheimer is taking advantage of Georgia’s internationally acclaimed workforce training program, Quick Start. The approximately 120 new jobs to be created in the medium term will include executive, adminis-trative, supervisory and production positions.

“Georgia’s healthcare industry is uniquely poised to help Gerresheimer grow,” said Nathan Deal, Georgia’s Governor. “This leading global company is taking advantage of an eager, skilled workforce and an advanced life science and healthcare ecosystem. Our state is the ideal location to support Gerresheimer’s newest expansion.”

Gerresheimer established its first Peachtree City production facility in 1993 and expanded it in 2009 with the establishment of a Technical Competence Center (TCC). The plant in Peachtree City is part of Gerresheimer’s Medical Plastic Systems business unit. Gerresheimer Headquarters is based in Düsseldorf, Germany. Peachtree City and the other plants in this business unit develop, industrialize, manufacture, and assemble customer-specific devices, such as inhalers, insulin pens, lancets, and various diagnostic systems.

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products the company contrib-utes to health and well-being. Gerresheimer has worldwide operations and its 11,000 employees manufacture products in local markets, close to its customers. With over 40 plants in Europe, North America, South America and Asia, Gerresheimer generates revenues of more than EUR 1.2 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry. For more information, visit www.gerresheimer.com.